Evidence map›Paper›PMID 28400730›Full record

ArticleFrontiers in pharmacology2017

Biocompatible Colloidal Suspensions Based on Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Toxicological Profile.

Dorina-Elena Coricovac, Elena-Alina Moacă, Iulia Pinzaru, Cosmin Cîtu, Codruta Soica, Ciprian-Valentin Mihali, Cornelia Păcurariu, Victor A Tutelyan, Aristidis Tsatsakis, Cristina-Adriana Dehelean

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. FeNanomaterials (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Chemical and Antimicrobial Characterization ofMolecules (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Comparative Evaluation of the Potential Antitumor ofPlants (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Toxicological Aspects of Iron Oxide Nanoparticles.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Dorina-Elena CoricovacFaculty of Pharmacy, "Victor Babecs" University of Medicine and Pharmacy Timişoara, Romania.
Elena-Alina MoacăFaculty of Pharmacy, "Victor Babecs" University of Medicine and Pharmacy Timişoara, Romania.
Iulia PinzaruFaculty of Pharmacy, "Victor Babecs" University of Medicine and Pharmacy Timişoara, Romania.
Cosmin CîtuFaculty of Medicine, "Victor Babeş" University of Medicine and Pharmacy Timişoara, Romania.
Codruta SoicaFaculty of Pharmacy, "Victor Babecs" University of Medicine and Pharmacy Timişoara, Romania.
Ciprian-Valentin Mihali"George Emil Palade" Electron Microscopy Center, Institute of Life Sciences, "Vasile Goldiş" Western University of Arad Arad, Romania.
Cornelia PăcurariuFaculty of Industrial Chemistry and Environmental Engineering, Politehnica University of Timişoara Timişoara, Romania.
Victor A TutelyanFederal Research Centre of Nutrition, Biotechnology and Food Safety Moscow, Russia.
Aristidis TsatsakisDepartment of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete Crete, Greece.
Cristina-Adriana DeheleanFaculty of Pharmacy, "Victor Babecs" University of Medicine and Pharmacy Timişoara, Romania.
Victor Babeș University of Medicine and Pharmacy Timișoara · ROFederal Research Centre of Nutrition and Biotechnology · RUPolytechnic University of Timişoara · ROUniversity of Crete · GRVasile Goldis Western University of Arad · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of magnetic iron oxide nanoparticles in biomedicine has evolved intensely in the recent years due to the multiple applications of these nanomaterials, mainly in domains like cancer. The aim of the present study was: (i) to develop biocompatible colloidal suspensions based on magnetic iron oxide nanoparticles as future theranostic tools for skin pathology and (ii) to test their effects

Indexed as

bioavailabilitycolloidal suspensionsmagnetic iron oxide nanoparticlesskin barriersolution combustion synthesistoxicity

Identifiers

PMID28400730
PMCPMC5368253
OpenAlexW2597521513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.